Pharmaceutical
Medical
Health

Abbott

$87.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (0.22%) As of 10:15 AM EDT today
+$0.19 (0.22%) Today

Why Robinhood?

You can buy or sell Abbott and other stocks, options, ETFs, and crypto commission-free!

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. Read More The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Employees
103,000
Headquarters
Abbott Park, Illinois
Founded
1888
Market Cap
154.35B
Price-Earnings Ratio
53.52
Dividend Yield
1.60
Average Volume
5.29M
High Today
$87.89
Low Today
$87.27
Open Price
$87.36
Volume
913.60K
52 Week High
$88.33
52 Week Low
$62.87

Collections

Pharmaceutical
Medical
Health
Medical Devices
Healthcare
Manufacturing
Technology
US

ABT News

BenzingaJul 18

'Fast Money' Final Trades From July 17: Abbott Labs, Gold And More

182
BenzingaJul 17

Abbott Laboratories Reports Q2 Earnings Beat

210
MarketWatchJul 17

Abbott stock rises after earnings beat, full-year guidance boost

101

ABT Earnings

$0.58
$0.66
$0.74
$0.82
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$0.80 per share
Actual
$0.82 per share

Popular Stocks

More ABT News

ReutersJul 16

Abbott to hike production of lower-cost glucose monitors as diabetes soars

20
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.